These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Perioral dermatitis in children under steroid inhalation therapy]. Held E; Ottevanger V; Petersen CS; Weismann K Ugeskr Laeger; 1997 Nov; 159(47):7002-3. PubMed ID: 9417708 [TBL] [Abstract][Full Text] [Related]
25. GOAL--asthma control, but at what cost? Todd GR Am J Respir Crit Care Med; 2005 Jul; 172(2):254-5. PubMed ID: 16002572 [No Abstract] [Full Text] [Related]
26. Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma. Miyahara H; Korematsu S; Nagakura T; Izumi T Pediatr Int; 2008 Feb; 50(1):103-8. PubMed ID: 18279216 [TBL] [Abstract][Full Text] [Related]
27. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009. Bayat A; Hjalgrim H; Møller RS Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844 [TBL] [Abstract][Full Text] [Related]
28. A 7-month-old boy with failure to thrive. Listernick R Pediatr Ann; 2010 Feb; 39(2):56-60. PubMed ID: 20166632 [No Abstract] [Full Text] [Related]
29. Fluticasone for the treatment of symptomatic bronchial asthma in children treated with sodium cromogylate--a prospective, randomised trial. von Berg A; Gappa M; Steinkamp G; Eur J Med Res; 2002 Jun; 7(6):257-64. PubMed ID: 12117660 [TBL] [Abstract][Full Text] [Related]
30. [Fluticasone propionate in children and infants with asthma]. Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359 [TBL] [Abstract][Full Text] [Related]
31. [Adrenal insufficiency secondary to the use of inhaled corticosteroids]. Shukla A; Nørrelund H Ugeskr Laeger; 2011 Sep; 173(39):2420-1. PubMed ID: 21958486 [TBL] [Abstract][Full Text] [Related]
33. Lawsuit raises questions about variant interpretation and communication: Ambiguity of lab and clinician roles could be at issue if case proceeds. Am J Med Genet A; 2017 Apr; 173(4):838-839. PubMed ID: 28328123 [No Abstract] [Full Text] [Related]
34. Genetic diagnosis of severe myoclonic epilepsy of infancy (Dravet syndrome) with SCN1A mutations in the Hong Kong Chinese patients. Mak CM; Chan KY; Yau EK; Chen SP; Siu WK; Law CY; Lam CW; Chan AY Hong Kong Med J; 2011 Dec; 17(6):500-2. PubMed ID: 22147323 [TBL] [Abstract][Full Text] [Related]
35. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018 [TBL] [Abstract][Full Text] [Related]
36. Comment on: obtaining concomitant control of allergic rhinitis and asthma with intranasal corticosteroid. Vaidyanathan S; Nair A; Lipworth BJ Allergy; 2007 Oct; 62(10):1214. PubMed ID: 17578497 [No Abstract] [Full Text] [Related]
37. Dravet syndrome and parkinsonism: A case report investigating the dopaminergic system. Deuel L; Collins AE; Maa EH; Barr JP; Kern DS Neurology; 2019 Sep; 93(13):595-596. PubMed ID: 31444242 [No Abstract] [Full Text] [Related]
38. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. Ducharme FM; Lemire C; Noya FJ; Davis GM; Alos N; Leblond H; Savdie C; Collet JP; Khomenko L; Rivard G; Platt RW N Engl J Med; 2009 Jan; 360(4):339-53. PubMed ID: 19164187 [TBL] [Abstract][Full Text] [Related]
39. Very high dose inhaled corticosteroids: panacea or poison? Russell G Arch Dis Child; 2006 Oct; 91(10):802-4. PubMed ID: 16990353 [TBL] [Abstract][Full Text] [Related]
40. Side-effects of fluticasone in asthmatic children: no effects after dose reduction. Visser MJ; van der Veer E; Postma DS; Arends LR; de Vries TW; Brand PL; Duiverman EJ Eur Respir J; 2004 Sep; 24(3):420-5. PubMed ID: 15358701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]